Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31033170 | 0.86 | DRD4 (0.67) | DRD4ALDH1A1TP53KCNH2MEN1 | |
| SCHEMBL31033189 | 0.77 | DRD2 (0.64) | DRD4ALDH1A1TP53DRD2 | |
| SCHEMBL14108085 | 0.77 | NOTUM (0.46) | ALDH1A1TP53MEN1KMT2A | |
| SCHEMBL31033213 | 0.76 | DRD2 (0.56) | DRD4ALDH1A1TP53MEN1KMT2A | |
| SCHEMBL6714648 | 0.76 | HTR1A (0.49) | DRD4DRD2HTR2AMCHR1 | |
| SCHEMBL31033183 | 0.76 | KMT2A (0.56) | ALDH1A1TP53KCNH2KMT2ADRD2 | |
| SCHEMBL2674982 | 0.76 | DRD2 (0.66) | DRD4DRD2 | |
| SCHEMBL5134628 | 0.74 | DRD4 (0.66) | DRD4ALDH1A1KCNH2MEN1KMT2A | |
| SCHEMBL26237334 | 0.73 | PRMT5 (0.44) | ALDH1A1MEN1KMT2A | |
| SCHEMBL2754100 | 0.73 | MEN1 (0.53) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024163956-A2 | SIGMA RECEPTOR LIGAND COMPOUNDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-08 | — | — | WO | disclosed |